Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss affects 20% of people, more in men and those over 35, and is often associated with a sensitive scalp.

Some medications caused temporary health issues that improved after stopping the drugs, but two patients died from liver problems linked to carbamazepine.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Cinnamon may help manage obesity and improve conditions related to Polycystic Ovary Syndrome (PCOS).

Metformin reduces certain hormone levels in men with early-onset hair loss.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Cinnamon can help manage symptoms of polycystic ovary syndrome, improve menstrual cycles and fertility, and positively affect cholesterol and blood sugar levels, but more research is needed to confirm these effects and find the best dosage.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

A woman with lupus had rare severe symptoms but improved with treatment.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Some common medications can harm male fertility, but many effects can be reversed.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.